|
AGPHD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.52449999957227E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.974340E-02 |
| Stage1-vs-Stage3 |
8.126400E-01 |
| Stage1-vs-Stage4 |
1.642350E-04 |
| Stage2-vs-Stage3 |
1.518200E-02 |
| Stage2-vs-Stage4 |
8.04810000000211E-05 |
| Stage3-vs-Stage4 |
8.375200E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.23539972590936E-10 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
3.151400E-01 |
| Caucasian-vs-Asian |
9.965600E-01 |
| AfricanAmerican-vs-Asian |
4.328200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
6.666800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.11270000002772E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.795160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.833500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.160200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.634400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.124800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.173400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.945600E-02 |
| Classical-VS-Follicular |
9.77649960987037E-10 |
| Classical-VS-Other |
3.866400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.64730007412572E-10 |
| Tall-VS-Other |
2.354600E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
8.089600E-01 |
| Follicular-VS-Normal |
2.67789999952583E-07 |
| Other-VS-Normal |
1.896960E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.52981999999025E-05 |
|
|
